The bill amends the definition of "prescription" in Minnesota Statutes 2022, section 151.01, subdivision 16a, to include patient-specific indications for use. It specifies that a valid prescription must now include instructions written in plain English explaining how the patient should use the drug. Additionally, the bill mandates the Board of Pharmacy to adopt rules that require prescription labels to contain the complete and unabbreviated generic name of the drug, plain English instructions for use, and the clinical indications for the drug.

Furthermore, the bill outlines the effective dates for these changes, stating that the amendments will take effect when the corresponding rules adopted by the Board of Pharmacy are effective under Minnesota Statutes, section 14.18. The rulemaking process must comply with Minnesota Statutes, section 14.389, ensuring that the new labeling requirements are properly implemented.

Statutes affected:
Introduction: 151.01